GRIP2 min read
GRIP2 min read
Julie DiMauro53 min listen
We explored how small and mid-sized pharmaceutical and biotech companies can avoid costly early compliance mistakes and minimize risk as they scale.
Alexander Barzacanos7 min read
The charges reflect the SEC’s sustained focus on accurate cybersecurity statements.
Alexander Barzacanos1 min read
The company failed to properly inform investors about regulatory challenges it was experiencing with the FDA.
Alexander Barzacanos2 min read
Elanco’s use of sales incentives created misleading impressions of customer demand, the SEC stated.
Alexander Barzacanos1 min read
The four settlements come nearly one year after the SEC sued SolarWinds for misleading investors about its cybersecurity controls.
Alexander Barzacanos, Julie DiMauro3 min read
The agency accused Icahn and his company of failing to disclose billions in shares used to secure personal margin loans.
Alexander Barzacanos1 min read
The SEC settled fraud charges against Ideanomics, its CEO and two former executives for misleading financial reporting and disclosures.
Julie DiMauro3 min read
SEC alleges the firm and representative failed to exercise reasonable diligence, care, and skill in making recommendations.
Julie DiMauro4 min read